Trial Profile
Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial: Extended Follow-up Study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RESET: Extended follow up study
- 06 Feb 2018 New trial record